Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / SGIOY - ViiV Healthcare's Juluca shows sustained treatment effect in studies

SGIOY - ViiV Healthcare's Juluca shows sustained treatment effect in studies

Shionogi & Co. Ltd. ADR
  • ViiV Healthcare, the HIV-focused joint venture between GlaxoSmithKline (NYSE:GSK), Pfizer (NYSE:PFE) and Shionogi (OTCPK:SGIOY) presents three year results from the SWORD 1 & 2 studies.
  • More news on: GlaxoSmithKline plc, Pfizer Inc., Shionogi & Co., Ltd., Healthcare stocks news,
    • Read more ...
Stock Information
Company Name: Shionogi & Co. Ltd. ADR
Stock Symbol: SGIOY
Market: OTC
Menu
SGIOY SGIOY Quote SGIOY Short SGIOY News SGIOY Articles SGIOY Message Board
Get SGIOY Alerts

News, Short Squeeze, Breakout and More Instantly...